Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?

Navid Sobhani; Silvia P Corona; Giandomenico Roviello; Stefan Bagby; Alberto D'Angelo; Giandomenico Iezzi; Daniele Generali

doi:10.2217/fon-2020-0311

Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?

Navid Sobhani, Silvia P Corona, Giandomenico Roviello, Stefan Bagby, Alberto D'Angelo, Giandomenico Iezzi, Daniele Generali

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (SciVal)

Original language	English
Pages (from-to)	1327-1330
Number of pages	4
Journal	Future oncology (London, England)
Volume	16
Issue number	19
Early online date	12 May 2020
DOIs	https://doi.org/10.2217/fon-2020-0311
Publication status	Published - 31 Jul 2020

Keywords

checkpoint inhibitors
immune markers
immune-gene signature
solid tumors

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/fon-2020-0311

Cite this

@article{39e4e3e1edcc4dfd89bd1b13e317da0d,

title = "Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?",

keywords = "checkpoint inhibitors, immune markers, immune-gene signature, solid tumors",

author = "Navid Sobhani and Corona, {Silvia P} and Giandomenico Roviello and Stefan Bagby and Alberto D'Angelo and Giandomenico Iezzi and Daniele Generali",

year = "2020",

month = jul,

day = "31",

doi = "10.2217/fon-2020-0311",

language = "English",

volume = "16",

pages = "1327--1330",

journal = "Future oncology (London, England)",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "19",

}

TY - JOUR

T1 - Immune-gene signature

T2 - a new tool for patient selection for checkpoint inhibitors?

AU - Sobhani, Navid

AU - Corona, Silvia P

AU - Roviello, Giandomenico

AU - Bagby, Stefan

AU - D'Angelo, Alberto

AU - Iezzi, Giandomenico

AU - Generali, Daniele

PY - 2020/7/31

Y1 - 2020/7/31

KW - checkpoint inhibitors

KW - immune markers

KW - immune-gene signature

KW - solid tumors

UR - http://www.scopus.com/inward/record.url?scp=85087111234&partnerID=8YFLogxK

U2 - 10.2217/fon-2020-0311

DO - 10.2217/fon-2020-0311

M3 - Comment/debate

C2 - 32396404

SN - 1479-6694

VL - 16

SP - 1327

EP - 1330

JO - Future oncology (London, England)

JF - Future oncology (London, England)

IS - 19

ER -

Immune-gene signature: a new tool for patient selection for checkpoint inhibitors?

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this